验证数据展示
经过测试的应用
Positive IF/ICC detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL555-66719 targets STK11/LKB1 in IF applications and shows reactivity with Human, Mouse, Rat samples.
经测试应用 | IF Application Description |
经测试反应性 | Human, Mouse, Rat |
免疫原 | STK11/LKB1 fusion protein Ag13436 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | serine/threonine kinase 11 |
别名 | LKB1, PJS, serine/threonine kinase 11, STK11 |
计算分子量 | 49 kDa |
观测分子量 | 45-49 kDa |
GenBank蛋白编号 | BC007981 |
基因名称 | LKB1 |
Gene ID (NCBI) | 6794 |
RRID | AB_2919693 |
偶联类型 | CoraLite®555 Fluorescent Dye |
最大激发/发射波长 | 557 nm / 570 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | Q15831 |
储存缓冲液 | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
STK11(serine/threonine-protein kinase 11) is also named as LKB1, PJS, and belongs to the protein kinase superfamily. It controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. The tumour suppressor protein LKB1 is a serine/threonine kinase that has been causally linked to Peutz-Jeghers syndrome (PJS). Defects in STK11 are a cause of Peutz-Jeghers syndrome (PJS) and defects in STK11 have been associated with testicular germ cell tumor (TGCT) and some sporadic cancers, especially lung cancers. STK11 has 2 isoforms with MW of 49 kDa and 45 kDa, and can be detected as 50-54 kDa after posttranslational modification.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL555 STK11/LKB1 antibody CL555-66719 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |